Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00324883 · ClinicalTrials.gov registry record
Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 81
- Enrollment target
NCT00324883: Completed study, sponsored by Weill Medical College of Cornell University.
NCT00324883 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00324883 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
We plan to assess the accuracy of a new means of estimating urine sodium excretion. We will compare the chloride to creatinine ratio obtained by titrator sticks with urine sodium measured by a standard laboratory. If found to approximate sodium excretion, the titrator sticks could provide a convenient means for doctors and patients to monitor their salt intake.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2006-03 |
| Est. Completion | 2010-06 |
What the finished NCT00324883 record still lists
NCT00324883 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00324883 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00324883 about?
NCT00324883 is a clinical study titled "Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium". We plan to assess the accuracy of a new means of estimating urine sodium excretion. We will compare the chloride to creatinine ratio obtained by titrator sticks with urine sodium measured by a standard laboratory. If found to approximate sodium excretion, the titrator sticks could provide a convenie...
What is the current status of trial NCT00324883?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2006-03. Estimated completion is 2010-06.
Who is sponsoring clinical trial NCT00324883?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia